Dear Members, Are you an experienced PK/PD modeling scientist ready to take your skills to the next level? Then you are invited to join Dr. Daniel Weiner for the 17th Advanced Level Workshop on Pharmacokinetic-Pharmacodynamic Data Analysis in Princeton, NJ. Register today and receive a 20% discount! (expires June 17th)
17th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis August 17-20, 2015 Princeton, NJ Register Here: https://www.certara.com/training/classes/105 Learn to apply advanced approaches for conducting PK/PD analysis. This course aims to give the course participants confidence and encouragement to have a go at PK/PD and to practice PK/PD data analysis on real life case studies from discovery, preclinical and development. The program is comprised of lectures and group exercises with discussion, combined with hands-on PK/PD data analysis sessions. Lectures will cover many topics including experimental design, target mediated drug disposition, instantaneous and delayed drug responses, effect-compartment, turnover and binding models, functional adaptation, transduction, mixture dynamics, drug-combination pd, pattern recognition, pop pk and translational aspects of PK and PD. Who should attend? Scientists with at least five years of experience in PK/PD modeling. Qualified graduate students. Topics include: Dose-response-time analysis, advanced principles of turnover modeling including modeling tolerance and rebound, approaches to TMDD modeling, approaches to optimizing sampling collection times, modeling PD effects for combination drug treatments, pattern recognition, and translational aspects of PK/PD modeling. Daniel Weiner Ph.D. Dr. Weiner has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and bioequivalence assessment. Prior to his previous tenure with Pharsight as a Senior Vice President, Dr. Weiner held several management positions including Head, Biostatistics, Merrell Dow Pharmaceuticals; Vice President, Statistical Consultants, Inc.; Vice President, Syntex Development Research; Senior Vice President and Principal Scientist, Quintiles, and most recently, Senior Vice President and Global Head of Clinical Development at IVAX Research. Andre Keller Certara(tm) 5520 Dillard Dr., Suite 260 Cary, NC 27518 Tel +1-919-852-4611 www.certara.com<http://www.certara.com/> NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
